Sinovac vaccine triggered an immune response in more than 90% of patients in early human tests
New hope for a coronavirus vaccine as Chinese company Sinovac’s shot triggered an antibody response in more than 90% of patients, early data suggests Sinovac Biotech Ltd, based in Beijing, China, has developed a vaccine called CoronaVac that uses a dead strain of the coronavirus Phase I tested safety, with none of the participants reporting … Read more